Sunil Healthcare last traded at ₹70.00 (2026-10-13). Over the past month the stock moved -7.0%, three months the stock moved +10.0%, year the stock moved -13.9%. Its closing range over 52 weeks is ₹61.24 – ₹80.00, with the latest close 12.5% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1976, Sunil Healthcare Ltd is a certified manufacturer of Empty Hard Gelatin capsules shell and HPMC Capsules shell.[1]
Business Overview:[1][2] a) SHL was earlier engaged in trading (including merchant trading) agro based commodities, under brand Sunloc foods However, this was discontinued in FY20 b) Currently, it is mainly engaged in the manufacturing empty hard gelatin capsule (EHGC) shells and hydroxypropyl methyl cellulose (HPMC) and the choice in 9 sizes available are 00, 0SEL, 0EL, 0,1, 2, 3, 4, 5. c) The company is a Hard-shell capsule manufacturer in India and pioneer in double lock and triple lock technology for capsules in India. d) The company is WHO-GMP certified company and has also been recognized as Star Export House by GOI.
In the latest quarter (Jun 2026), Sunil Healthcare reported sales of ₹18.99 crore (-16.1%) and net profit of ₹0.46 crore (-49.5%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 18.99 | 2.93 | 15.43 | 0.46 | 0.45 |
| Mar 2026 | 19.72 | 1.94 | 9.84 | 1.52 | 1.48 |
| Dec 2025 | 21.84 | 3.62 | 16.58 | 0.59 | 0.58 |
| Sep 2025 | 23.52 | 3.93 | 16.71 | 1.00 | 0.98 |
| Jun 2025 | 22.64 | 3.27 | 14.44 | 0.91 | 0.89 |
| Mar 2025 | 21.20 | 3.03 | 14.29 | 0.36 | 0.35 |
| Dec 2024 | 20.46 | 2.70 | 13.20 | -0.54 | -0.53 |
| Sep 2024 | 20.26 | 2.31 | 11.40 | -0.55 | -0.54 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -14.5% | -9.7% | -0.5% | +5.3% | +16.1% | +6.7% | -7.0% | -16.1% |
| Operating profit growth | +89.3% | – | +13.1% | +48.0% | +70.1% | +34.1% | -36.0% | -10.4% |
| Net profit growth | – | – | +140.0% | – | – | – | +322.2% | -49.5% |
| EPS growth | – | – | +133.3% | – | – | – | +322.9% | -49.4% |
| OPM % | 11.4% | 13.2% | 14.3% | 14.4% | 16.7% | 16.6% | 9.8% | 15.4% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Sunil Healthcare reported sales of ₹87.72 crore (+5.2%) and net profit of ₹4.01 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 87.72 | 12.77 | 14.56 | 4.01 | 3.91 |
| Mar 2025 | 83.42 | 10.26 | 12.30 | -1.42 | -1.38 |
| Mar 2024 | 90.19 | 4.26 | 4.72 | -1.79 | -1.75 |
| Mar 2023 | 110.49 | 16.17 | 14.63 | 6.68 | 6.51 |
| Mar 2022 | 119.16 | 17.38 | 14.59 | 6.42 | 6.26 |
| Mar 2021 | 90.62 | 5.35 | 5.90 | -0.64 | -0.62 |
| Mar 2020 | 70.02 | -6.93 | -9.90 | -4.96 | -4.84 |
| Mar 2019 | 80.88 | 11.26 | 13.92 | -0.69 | -0.67 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -11.4% | -13.4% | +29.4% | +31.5% | -7.3% | -18.4% | -7.5% | +5.2% |
| Operating profit growth | -18.9% | -161.5% | – | +224.9% | -7.0% | -73.7% | +140.8% | +24.5% |
| Net profit growth | -115.4% | – | – | – | +4.0% | -126.8% | – | – |
| EPS growth | -115.3% | – | – | – | +4.0% | -126.9% | – | – |
| OPM % | 13.9% | -9.9% | 5.9% | 14.6% | 14.6% | 4.7% | 12.3% | 14.6% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Sunil Healthcare.
Get Free AI Stock Analysis FREE →2 healthcare stocks where Ashish Kacholia and Sunil Singhania ignored falling promoter stakes
Why Ashish Dhawan and Sunil Singhania are betting big on 2 ignored healthcare stocks
Why Ashish Dhawan and Sunil Singhania are betting big on 2 ignored healthcare stocks
Sunil Healthcare shares were last quoted at ₹70.00 (-3.4% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Sunil Healthcare has a price-to-earnings (P/E) ratio of 20.32 and a price-to-book (P/B) ratio of 1.04. The industry P/E is 53.33.
The 52-week high of Sunil Healthcare is ₹82.84 and the 52-week low is ₹56.35.
The market capitalisation of Sunil Healthcare is about ₹72.30 crore.
In the latest quarter (Jun 2026), Sunil Healthcare reported sales of ₹18.99 crore (-16.1%) and net profit of ₹0.46 crore (-49.5%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Sunil Healthcare has a 3-year ROE of 1.00%, 3-year profit growth of -15.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 73.53% of Sunil Healthcare.
Sunil Healthcare belongs to the Pharmaceuticals & Drugs sector.